secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2022-02-08T23:59:59+00:00
Accession:  0001213900-22-005920
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larkspur Health Acquisition units may separate into common stock and warrants starting Feb 10, 2022
--------------------------------------------------------------------------------

- Units trade as LSPRU; separated common stock as LSPR, warrants as LSPRW on Nasdaq.
- Separation effective February 10, 2022; holders must contact transfer agent Continental Stock Transfer.
- No fractional warrants will be issued; only whole warrants will trade separately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000121390022005920/0001213900-22-005920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000121390022005920/ea155040-8k_larkspur.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-005920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer